Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-21-038954

Options or other derivatives

  • Director acquired 7,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JEFFS ROGER Director 2021-06-04 Grant or award · Stock Option (Right to Buy) +7,325 7,325 D
Loading xslF345X03/doc4.xml…